Notably, miR-320a was found to be downregulated in bladder cancer cells, and it was proposed to function as a tumor suppressor by targeting the integrin subunit beta 3 gene (ITGB3) and inhibiting cell invasion (31). The gene discussed is ITGB3; the disease is urinary bladder carcinoma.